相似文献
1
Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience.
Indian J Nucl Med. 2012 Oct;27(4):246-8. doi: 10.4103/0972-3919.115396.
2
Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Clin Nucl Med. 2011 Jan;36(1):1-7. doi: 10.1097/RLU.0b013e3181feeb5e.
3
Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
AJR Am J Roentgenol. 2008 Apr;190(4):1085-90. doi: 10.2214/AJR.07.2107.
4
The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.
Ann Surg Oncol. 2010 Feb;17(2):392-400. doi: 10.1245/s10434-009-0850-5. Epub 2009 Dec 1.
5
Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
Nucl Med Commun. 2015 Mar;36(3):251-9. doi: 10.1097/MNM.0000000000000239.
6
Incremental value of Tc-HYNIC-TOC SPECT/CT over whole-body planar scintigraphy and SPECT in patients with neuroendocrine tumours.
Nuklearmedizin. 2017 Jun 12;56(3):97-107. doi: 10.3413/Nukmed-0851-16-10. Epub 2017 Feb 6.
7
Utility of single-photon emission tomography/computed tomography for sentinel lymph node localization in breast cancer patients.
Nucl Med Commun. 2017 Jun;38(6):493-499. doi: 10.1097/MNM.0000000000000676.
8
A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy, Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography.
Mol Imaging Radionucl Ther. 2017 Feb 5;26(1):38-42. doi: 10.4274/mirt.70894.
9
Does the Incremental Value of I-Metaiodobenzylguanidine SPECT/CT over Planar Imaging Justify the Increase in Radiation Exposure?
Nucl Med Mol Imaging. 2021 Aug;55(4):173-180. doi: 10.1007/s13139-021-00707-5. Epub 2021 Jul 7.
10
Value of SPECT/CT in Diagnostic I-131 MIBG Scintigraphy in Patients with Neuroblastoma.
Nucl Med Mol Imaging. 2018 Oct;52(5):350-358. doi: 10.1007/s13139-018-0532-y. Epub 2018 Jul 16.
引用本文的文献
1
The Utility of Nuclear Imaging in Hypertrophic Cardiomyopathy: A Narrative Review.
J Clin Med. 2025 Mar 22;14(7):2183. doi: 10.3390/jcm14072183.
本文引用的文献
1
Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
AJR Am J Roentgenol. 2008 Apr;190(4):1085-90. doi: 10.2214/AJR.07.2107.
2
Imaging of neuroendocrine tumors.
Hematol Oncol Clin North Am. 2007 Jun;21(3):409-32; vii. doi: 10.1016/j.hoc.2007.04.006.
3
Imaging of neuroendocrine tumors.
Semin Nucl Med. 2006 Jul;36(3):228-47. doi: 10.1053/j.semnuclmed.2006.03.007.
4
Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy.
Nuklearmedizin. 2004 Oct;43(5):164-70. doi: 10.1055/s-0038-1625200.
5
Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.
Q J Nucl Med Mol Imaging. 2004 Jun;48(2):150-63.
6
The diagnosis and medical management of advanced neuroendocrine tumors.
Endocr Rev. 2004 Jun;25(3):458-511. doi: 10.1210/er.2003-0014.
7
Functional-anatomical image fusion in neuroendocrine tumors.
Cancer Biother Radiopharm. 2004 Feb;19(1):129-34. doi: 10.1089/108497804773391775.
8
131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP132-9. doi: 10.1007/s00259-003-1357-0.
9
Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):835-43. doi: 10.1007/s00259-003-1160-y. Epub 2003 Apr 8.
10
Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors.
Semin Nucl Med. 1985 Apr;15(2):132-53. doi: 10.1016/s0001-2998(85)80022-2.
Zotero 插件
